Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
about
Serum microRNA signatures identified by Solexa sequencing predict sepsis patients' mortality: a prospective observational studyMicro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisHepatic Stellate Cells and microRNAs in Pathogenesis of Liver FibrosisCirculating MicroRNAs as Biomarkers for SepsisNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyFunction and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver DiseaseExosomes as miRNA Carriers: Formation-Function-FutureEbola: translational science considerationsMicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapyMiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinomaHepatic disease biomarkers and liver transplantation: what is the potential utility of microRNAs?The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrestMicroRNAs in liver diseasePre-profiling factors influencing serum microRNA levelsCirculating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease.Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinomaSerum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth diseaseHepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation.Complex interactions between microRNAs and hepatitis B/C viruses.Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expressionSerum microRNA-122 predicts survival in patients with liver cirrhosis.Comprehensive miRNA expression analysis in peripheral blood can diagnose liver diseaseCirculating RNA molecules as biomarkers in liver disease.MicroRNA 3' end nucleotide modification patterns and arm selection preference in liver tissuesDistinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers.Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a choline- and folate-deficient diet.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Differential stability of cell-free circulating microRNAs: implications for their utilization as biomarkers.Differential expression profiling of spleen microRNAs in response to two distinct type II interferons in Tetraodon nigroviridis.MicroRNAs: Role in Hepatitis C Virus pathogenesisCirculating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis BIncreased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infectionParallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.Circulating miRNA profile in HCV infected serum: novel insight into pathogenesis.Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression.Micro-RNA-122 levels in acute liver failure and chronic hepatitis C.
P2860
Q21134526-B341DD86-84F9-4EC8-8D99-4644DFC9DBEFQ21560965-BAD00C49-33A4-40A7-B50C-398613A6728DQ26752932-72879399-D8AA-42C9-91F4-C20DEAC24E09Q26772133-00D3DC8B-0905-4C29-A5EB-3B3B8294243CQ27015035-1F7D7CFA-B8F8-4829-8685-6834A99B8349Q27015778-F6CD72A4-227E-423F-96BA-B9BBEF897CA6Q28073703-25246886-817D-46B0-9C30-29B58B1FB682Q28075728-7222598E-4794-42F0-B1B5-381F7FF60FC2Q28082994-B25D3310-EE03-49FA-8BF5-3A34623D9B0DQ28538780-22A2BB85-58AA-4687-A36A-C3F90F016F4DQ28658442-CA75AE25-4633-42E3-B772-C9DD4CB94D7BQ30456435-576827AF-16FF-42AE-BF9E-F0DA26291547Q33754641-BF962ADF-1D88-4DFE-A73B-CFC097064424Q33880442-B3BF39BB-7DE2-4EF6-AB2B-3DA5C7D4578DQ33936328-8455AD3F-C55D-4ED7-800B-E52B38E4879FQ34009053-825CC2F8-5134-467B-A2BF-C868D58A9298Q34069652-FD1AE0D1-5FCF-4DDE-92DF-E8CE063F0BCDQ34075488-C79557D7-44DD-4A34-87F7-32EC51C6883AQ34217838-3F752BD6-8103-4099-9CCE-FDE7B52E52CFQ34302987-CA2800B9-1D76-4A10-8744-B44379AEE7A7Q34425208-F6812138-B399-4624-AFCA-738EEFBF31FCQ34429711-CBA36584-964F-4F7A-8A50-FAB33139F4B6Q34477192-3A9AC96A-E8CD-49AA-AD83-5EEB8AD5A275Q34486635-C32AE991-2830-4C9B-B966-C78A0273FC44Q34530125-BA62CCEB-3216-4F78-BAAD-BF362E5342B3Q34776270-82A55E0C-4FB6-4F7A-ACFB-80DCF249BFBCQ34796362-3909F613-192F-44E7-9148-05B901493B1BQ34821020-E5CE8B4A-24AF-4E5A-A583-735C928ABEB0Q35000824-11ACB0D7-8B81-4A71-ACD4-B0C0E093B81DQ35163626-A07A22B1-7434-4C42-AAB9-00E98B57A63AQ35606627-7D900297-5404-4AC0-8E87-00224CF71E7BQ35843599-3E79B954-FAD2-4227-919E-C466DA203970Q36246282-5AD0C8B6-8F23-4A34-8B79-411B1C68B64AQ36310416-91B44574-77F8-4720-A27C-4A4BC0D48087Q36335088-A80B6B21-9DD1-4349-89DE-7DFFCC5358B7Q36602293-417495B9-C8BD-4804-B978-197705D27371Q36737114-D97EA399-97E9-4720-B4D6-ED740DFDD133Q36835537-F3B87789-8D42-4207-B58A-15899E3402C9Q36875670-56802132-3551-4B4C-ACC7-0EFD493F99A8Q37060162-EF086FC2-F7E6-4167-93EF-DA465591E57B
P2860
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@ast
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@en
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@nl
type
label
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@ast
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@en
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@nl
prefLabel
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@ast
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@en
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@nl
P2093
P2860
P50
P356
P1476
Serum miR-122 as a biomarker o ...... c hepatitis C virus infection.
@en
P2093
Bernd Kronenberger
Christoph Sarrazin
Eva Herrmann
Jan Peveling-Oberhag
Jörg Haupenthal
Mireen Friedrich-Rust
Nicole Forestier
Oliver Waidmann
Verena Bihrer
P2860
P2888
P304
P356
10.1038/AJG.2011.161
P407
P577
2011-05-24T00:00:00Z
P5875
P6179
1022470665